We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement.
- Authors
Tae Jung Oh; Ju-Young Moon; Kyu Yeon Hur; Seung Hyun Ko; Hyun Jung Kim; Taehee Kim; Dong Won Lee; Min Kyong Moon
- Abstract
Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome trials of sodium-glucose cotransporter-2 (SGLT2) inhibitor showed profound reno-protective effects. The Korean Diabetes Association and the Korean Society of Nephrology reviewed clinical trials and performed meta-analysis to assess the effects of SGLT2 inhibitors on the preservation of estimated glomerular filtration rate (eGFR). We limited the data of SGLT2 inhibitors which can be prescribed in Korea. Both eGFR value and its change from the baseline were significantly more preserved in the SGLT2 inhibitor treatment group compared to the control group after 156 weeks. However, some known adverse events were increased in SGLT2 inhibitor treatment, such as genital infection, diabetic ketoacidosis, and volume depletion. We recommend the long-term use SGLT2 inhibitor in patients with type 2 diabetes mellitus (T2DM) for attenuation of renal function decline. However, we cannot generalize our recommendation due to lack of long-term clinical trials testing reno-protective effects of every SGLT2 inhibitor in a broad range of patients with T2DM. This recommendation can be revised and updated after publication of several large-scale renal outcome trials.
- Subjects
SOUTH Korea; TYPE 2 diabetes; DIABETES; GLOMERULAR filtration rate; CHRONIC kidney failure; SODIUM-glucose cotransporter 2 inhibitors
- Publication
Diabetes & Metabolism Journal, 2020, Vol 44, Issue 4, p489
- ISSN
2233-6079
- Publication type
Article
- DOI
10.4093/dmj.2020.0172